RHOXF1
geneOn this page
Also known as OTEXPEPP1
Summary
RHOXF1 (Rhox homeobox family member 1, HGNC:29993) is a protein-coding gene on chromosome Xq24, encoding Rhox homeobox family member 1 (Q8NHV9). Transcription factor maybe involved in reproductive processes.
This gene is a member of the PEPP subfamily of paired-like homoebox genes. The gene may be regulated by androgens and epigenetic mechanisms. The encoded nuclear protein is likely a transcription factor that may play a role in human reproduction.
Source: NCBI Gene 158800 — RefSeq curated summary.
At a glance
- Gene–disease (curated): spermatogenic failure (Moderate, GenCC)
- Clinical variants (ClinVar): 44 total
- MANE Select transcript:
NM_139282
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29993 |
| Approved symbol | RHOXF1 |
| Name | Rhox homeobox family member 1 |
| Location | Xq24 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OTEX, PEPP1 |
| Ensembl gene | ENSG00000101883 |
| Ensembl biotype | protein_coding |
| OMIM | 300446 |
| Entrez | 158800 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000217999, ENST00000422226, ENST00000555168, ENST00000701130, ENST00000701644, ENST00000703667, ENST00000956250, ENST00000956251
RefSeq mRNA: 1 — MANE Select: NM_139282
NM_139282
CCDS: CCDS14593
Canonical transcript exons
ENST00000217999 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000675731 | 120112869 | 120112914 |
| ENSE00000675733 | 120115465 | 120115913 |
| ENSE00001187848 | 120109051 | 120109302 |
Expression profiles
Bgee: expression breadth ubiquitous, 149 present calls, max score 92.94.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0229 / max 18.9456, expressed in 5 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200333 | 0.0086 | 4 |
| 200334 | 0.0082 | 3 |
| 200335 | 0.0062 | 3 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.94 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.24 | gold quality |
| right testis | UBERON:0004534 | 81.43 | gold quality |
| left testis | UBERON:0004533 | 80.88 | gold quality |
| testis | UBERON:0000473 | 79.88 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 77.22 | gold quality |
| right uterine tube | UBERON:0001302 | 76.35 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 75.48 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.24 | gold quality |
| cerebellum | UBERON:0002037 | 73.40 | gold quality |
| granulocyte | CL:0000094 | 70.20 | gold quality |
| right ovary | UBERON:0002118 | 66.12 | gold quality |
| right frontal lobe | UBERON:0002810 | 65.97 | gold quality |
| left ovary | UBERON:0002119 | 65.31 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 63.63 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 63.38 | gold quality |
| adipose tissue | UBERON:0001013 | 62.96 | gold quality |
| hypothalamus | UBERON:0001898 | 62.81 | gold quality |
| ovary | UBERON:0000992 | 62.73 | gold quality |
| left uterine tube | UBERON:0001303 | 62.50 | gold quality |
| metanephros cortex | UBERON:0010533 | 62.40 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 62.29 | gold quality |
| adult organism | UBERON:0007023 | 62.14 | gold quality |
| lower esophagus | UBERON:0013473 | 62.06 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 62.03 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 61.89 | gold quality |
| skin of hip | UBERON:0001554 | 61.48 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 61.47 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 61.10 | gold quality |
| primary visual cortex | UBERON:0002436 | 61.08 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 30.19 |
| E-ANND-3 | no | 0.96 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| BCL2 | Activation |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0719.1 | RHOXF1 | Paired-related HD factors |
| MA0719.2 | RHOXF1 | Paired-related HD factors |
JASPAR matrix evidence (PMIDs): PMID:18585360
miRNA regulators (miRDB)
16 targeting RHOXF1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-519A-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519B-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519C-3P | 99.67 | 71.67 | 1870 |
| HSA-MIR-519D-5P | 99.41 | 69.30 | 2057 |
| HSA-MIR-5693 | 99.24 | 66.67 | 1106 |
| HSA-MIR-4293 | 99.22 | 65.46 | 1263 |
| HSA-MIR-4784 | 99.15 | 67.41 | 1733 |
| HSA-MIR-3150B-3P | 98.81 | 67.21 | 1728 |
| HSA-MIR-3161 | 98.71 | 67.14 | 816 |
| HSA-MIR-2467-3P | 98.65 | 67.18 | 1969 |
| HSA-MIR-6781-3P | 97.44 | 66.85 | 970 |
| HSA-MIR-2682-3P | 97.10 | 66.16 | 840 |
| HSA-MIR-3152-5P | 96.98 | 66.88 | 819 |
| HSA-MIR-6888-5P | 95.89 | 63.78 | 831 |
Literature-anchored findings (GeneRIF, showing 2)
- cloning and characterization of human OTEX (PMID:11980563)
- Deleterious variants in X-linked RHOXF1 cause male infertility with oligo- and azoospermia. (PMID:38258527)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rhox13 | ENSMUSG00000050197 |
| rattus_norvegicus | Rhox13 | ENSRNOG00000028050 |
Paralogs (50): ARX (ENSG00000004848), PAX6 (ENSG00000007372), PAX7 (ENSG00000009709), ALX4 (ENSG00000052850), GSC2 (ENSG00000063515), PITX1 (ENSG00000069011), PAX2 (ENSG00000075891), CRX (ENSG00000105392), EVX1 (ENSG00000106038), PAX4 (ENSG00000106331), NOBOX (ENSG00000106410), PITX3 (ENSG00000107859), PHOX2B (ENSG00000109132), OTX1 (ENSG00000115507), PRRX1 (ENSG00000116132), VSX2 (ENSG00000119614), ESX1 (ENSG00000123576), PAX8 (ENSG00000125618), PAX1 (ENSG00000125813), RHOXF2 (ENSG00000131721), GSC (ENSG00000133937), RAX (ENSG00000134438), PAX3 (ENSG00000135903), ALX3 (ENSG00000156150), HESX1 (ENSG00000163666), PITX2 (ENSG00000164093), UNCX (ENSG00000164853), PHOX2A (ENSG00000165462), OTX2 (ENSG00000165588), DRGX (ENSG00000165606), PRRX2 (ENSG00000167157), SHOX2 (ENSG00000168779), OTP (ENSG00000171540), RAX2 (ENSG00000173976), EVX2 (ENSG00000174279), PROP1 (ENSG00000175325), ISX (ENSG00000175329), ALX1 (ENSG00000180318), MIXL1 (ENSG00000185155), SHOX (ENSG00000185960)
Protein
Protein identifiers
Rhox homeobox family member 1 — Q8NHV9 (reviewed: Q8NHV9)
Alternative names: Ovary-, testis- and epididymis-expressed gene protein, Paired-like homeobox protein PEPP-1
All UniProt accessions (1): Q8NHV9
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor maybe involved in reproductive processes. Modulates expression of target genes encoding proteins involved in processes relevant to spermatogenesis.
Subunit / interactions. Does not interact with itself.
Subcellular location. Nucleus.
Tissue specificity. Ovary, testis and epididymis. Also detected in the prostate and the mammary gland. Expressed in many tumor cell lines derived from acute lymphocytic leukemia, prostate, endometrial adenocarcinoma, melanoma, bladder carcinoma, colon carcinoma, erythroleukemia and breast carcinoma. Not expressed in placenta. In testis, mainly expressed in germ cells, but also detected in somatic cells such as Sertoli cells, Leydig cells and peritubular cells.
Domain organisation. Mutagenesis of amino acids 147 to 164 and 155 to 164 lead to a major cytoplasmic localization, with only minor localization in the nucleus.
Induction. By androgen.
Similarity. Belongs to the paired-like homeobox family. PEPP subfamily.
RefSeq proteins (1): NP_644811* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000047 | HTH_motif | Conserved_site |
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR050649 | Paired_Homeobox_TFs | Family |
Pfam: PF00046
UniProt features (11 total): sequence variant 6, chain 1, DNA-binding region 1, region of interest 1, short sequence motif 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NHV9-F1 | 65.63 | 0.27 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 33 (showing top):
GOBP_CELLULAR_RESPONSE_TO_LIPID, GOBP_NEUROGENESIS, GOBP_HORMONE_MEDIATED_SIGNALING_PATHWAY, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, GOBP_RESPONSE_TO_STEROID_HORMONE, GOBP_RESPONSE_TO_HORMONE, GOBP_RESPONSE_TO_LIPID, GOBP_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS, GOBP_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY, GOBP_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY, CONRAD_STEM_CELL, GOBP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chrXq24, MADAN_DPPA4_TARGETS
GO Biological Process (5): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), positive regulation of gene expression (GO:0010628), androgen receptor signaling pathway (GO:0030521), neuron development (GO:0048666)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), sequence-specific double-stranded DNA binding (GO:1990837), protein binding (GO:0005515)
GO Cellular Component (4): chromatin (GO:0000785), nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| regulation of gene expression | 2 |
| regulation of DNA-templated transcription | 2 |
| transcription cis-regulatory region binding | 2 |
| DNA-templated transcription | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription by RNA polymerase II | 1 |
| gene expression | 1 |
| positive regulation of macromolecule biosynthetic process | 1 |
| nuclear receptor-mediated steroid hormone signaling pathway | 1 |
| neuron differentiation | 1 |
| cell development | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription regulator activity | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
338 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RHOXF1 | AR | P10275 | 523 |
| RHOXF1 | UNC5C | O95185 | 462 |
| RHOXF1 | ZNF354C | Q86Y25 | 449 |
| RHOXF1 | PLTP | P55058 | 353 |
| RHOXF1 | GDAP1 | Q8TB36 | 353 |
| RHOXF1 | FBXO39 | Q8N4B4 | 330 |
| RHOXF1 | TGIF2LX | Q8IUE1 | 328 |
| RHOXF1 | DCAF4L1 | Q3SXM0 | 324 |
| RHOXF1 | DPRX | A6NFQ7 | 321 |
| RHOXF1 | ZSCAN1 | Q8NBB4 | 320 |
| RHOXF1 | PAGE2B | Q5JRK9 | 302 |
| RHOXF1 | D6RAR5 | D6RAR5 | 301 |
| RHOXF1 | MZF1 | P28698 | 297 |
| RHOXF1 | VCX3B | Q9H321 | 297 |
| RHOXF1 | ZNF502 | Q8TBZ5 | 290 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RHOXF1 | MAP1LC3C | psi-mi:“MI:0915”(physical association) | 0.560 |
| NPAS2 | RHOXF1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RHOXF1 | VTN | psi-mi:“MI:0915”(physical association) | 0.370 |
| RHOXF1 | MAP1LC3C | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (4): MAP1LC3C (Two-hybrid), RHOXF1 (Positive Genetic), RHOXF1 (Two-hybrid), VTN (Two-hybrid)
ESM2 similar proteins: A0A1W2PPF3, A0A3B3IT52, E9Q3T6, O02747, O13161, O42173, O57374, O73622, O95238, P01103, P01104, P09632, P0C7M4, P10242, P14837, P17278, P30561, P31538, P41738, P46200, Q1KKS8, Q28G02, Q32NH9, Q4JM65, Q5REX1, Q5WM45, Q66IG8, Q68EH7, Q6U8D7, Q6ZTZ1, Q7T1K4, Q8BIL2, Q8BKE5, Q8CFH6, Q8IWB6, Q8JIT7, Q8NHV9, Q8R4S2, Q8R4S4, Q8R4S5
Diamond homologs: A1A546, A1YEV8, A1YEY5, A1YFI3, A1YG25, A1YG57, A2T711, A2T733, A2T7P4, A6NNA5, A6YP92, F6YCR7, G5EC89, G5EDS1, O14813, O18400, O35085, O35137, O35160, O35602, O35690, O42115, O42201, O42356, O42357, O42358, O42567, O43186, O54751, O70137, O73917, O75360, O75364, O88436, O93385, O95076, O97039, P06601, P0C7M4, P26367
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| RHOXF1 | “up-regulates quantity by expression” | BCL2 | “transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
44 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 4 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
680 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:120112773:TTAGA:T | donor_gain | 1.0000 |
| X:120112910:CCCTT:C | acceptor_gain | 1.0000 |
| X:120112911:CCTTC:C | acceptor_gain | 1.0000 |
| X:120159414:G:GG | donor_gain | 1.0000 |
| X:120159424:GCG:G | donor_gain | 1.0000 |
| X:120159427:GTA:G | donor_loss | 1.0000 |
| X:120159428:T:A | donor_loss | 1.0000 |
| X:120163449:T:A | acceptor_gain | 1.0000 |
| X:120112791:AG:A | donor_gain | 0.9900 |
| X:120112912:CTT:C | acceptor_gain | 0.9900 |
| X:120112913:TT:T | acceptor_gain | 0.9900 |
| X:120112915:C:CC | acceptor_gain | 0.9900 |
| X:120115460:CTTA:C | donor_loss | 0.9900 |
| X:120115461:TTA:T | donor_loss | 0.9900 |
| X:120115462:TA:T | donor_loss | 0.9900 |
| X:120115463:A:AC | donor_gain | 0.9900 |
| X:120115463:A:C | donor_loss | 0.9900 |
| X:120115464:C:CC | donor_gain | 0.9900 |
| X:120115507:T:A | donor_gain | 0.9900 |
| X:120159427:G:GG | donor_gain | 0.9900 |
| X:120163453:T:A | acceptor_gain | 0.9900 |
| X:120163456:A:AG | acceptor_gain | 0.9900 |
| X:120163457:G:GG | acceptor_gain | 0.9900 |
| X:120163457:GATTT:G | acceptor_gain | 0.9900 |
| X:120109298:CAAAC:C | acceptor_gain | 0.9800 |
| X:120109300:AAC:A | acceptor_gain | 0.9800 |
| X:120109301:ACCTA:A | acceptor_loss | 0.9800 |
| X:120109302:CCTAC:C | acceptor_loss | 0.9800 |
| X:120109303:C:CC | acceptor_gain | 0.9800 |
| X:120109303:CTAC:C | acceptor_loss | 0.9800 |
AlphaMissense
1205 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:120109294:A:C | F151L | 0.999 |
| X:120109294:A:T | F151L | 0.999 |
| X:120109296:A:G | F151L | 0.999 |
| X:120115497:G:C | F122L | 0.999 |
| X:120115497:G:T | F122L | 0.999 |
| X:120115499:A:G | F122L | 0.999 |
| X:120109295:A:G | F151S | 0.997 |
| X:120115533:G:C | F110L | 0.997 |
| X:120115533:G:T | F110L | 0.997 |
| X:120115535:A:G | F110L | 0.997 |
| X:120115483:T:C | Y127C | 0.996 |
| X:120115498:A:G | F122S | 0.996 |
| X:120109282:C:A | R155S | 0.995 |
| X:120109282:C:G | R155S | 0.995 |
| X:120112903:G:T | A137D | 0.995 |
| X:120115534:A:C | F110C | 0.995 |
| X:120115481:G:A | P128S | 0.994 |
| X:120115499:A:C | F122V | 0.994 |
| X:120115534:A:G | F110S | 0.994 |
| X:120109296:A:T | F151I | 0.993 |
| X:120115498:A:C | F122C | 0.993 |
| X:120115499:A:T | F122I | 0.993 |
| X:120109295:A:C | F151C | 0.992 |
| X:120109296:A:C | F151V | 0.992 |
| X:120109270:C:A | R159S | 0.991 |
| X:120109270:C:G | R159S | 0.991 |
| X:120112904:C:G | A137P | 0.991 |
| X:120115480:G:T | P128H | 0.991 |
| X:120115510:A:G | L118P | 0.990 |
| X:120109285:T:A | K154N | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000927824 (X:120120963 G>A,T), RS1001155981 (X:120111814 T>C), RS1001599870 (X:120116858 G>A), RS1002051265 (X:120119349 A>G), RS1002114263 (X:120117228 C>A), RS1002221084 (X:120110309 G>A), RS1002336556 (X:120119004 G>T), RS1002713821 (X:120115275 C>A), RS1004397492 (X:120119576 C>G), RS1004940043 (X:120112735 T>C,G), RS1005515651 (X:120117617 C>A), RS1005661828 (X:120108667 A>G), RS1006154703 (X:120108997 A>G), RS1006413099 (X:120110375 C>T), RS1008432815 (X:120120556 C>T)
Disease associations
OMIM: gene MIM:300446 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| spermatogenic failure | Moderate | X-linked |
Mondo (1): spermatogenic failure (MONDO:0004983)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Decitabine | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Estradiol | decreases expression | 1 |
| Lead | increases expression | 1 |
| Malathion | increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: spermatogenic failure 50
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spermatogenic failure